These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1980369)

  • 21. [Clinical trial of oxyprothepin decanoate (author's transl)].
    Kabes J; Balon R; Hanzlícek L; Skovajsová M; Kozáková H
    Cesk Psychiatr; 1980 Feb; 76(1):16-25. PubMed ID: 6103755
    [No Abstract]   [Full Text] [Related]  

  • 22. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
    Cassan P
    Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
    [No Abstract]   [Full Text] [Related]  

  • 23. NIMH funds study of drugs for schizophrenia and Alzheimer's.
    J Psychosoc Nurs Ment Health Serv; 1999 Dec; 37(12):7. PubMed ID: 10618770
    [No Abstract]   [Full Text] [Related]  

  • 24. The first clinical study of BW-234U in schizophrenia.
    Davidson J; Miller R; Wingfield M; Zung W; Dren AT
    Psychopharmacol Bull; 1982 Oct; 18(4):173-6. PubMed ID: 6130560
    [No Abstract]   [Full Text] [Related]  

  • 25. Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials.
    Pecenak J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():49-70. PubMed ID: 17262007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of risperidone on positive features of schizophrenia.
    McEvoy JP
    J Clin Psychiatry; 1994 May; 55 Suppl():18-21. PubMed ID: 7520904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A trial of adjunctive imipramine in postpsychotic depression.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Casey E
    Psychopharmacol Bull; 1985; 21(1):114-6. PubMed ID: 2858903
    [No Abstract]   [Full Text] [Related]  

  • 28. Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.
    Stryjer R; Strous R; Bar F; Shaked G; Shiloh R; Rozencwaig S; Grupper D; Buchman N; Kotler M; Rabey JM; Weizman A
    Hum Psychopharmacol; 2004 Jul; 19(5):343-6. PubMed ID: 15252826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
    Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
    Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
    Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
    [No Abstract]   [Full Text] [Related]  

  • 31. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDA-Approved Drugs To Treat Schizophrenia.
    J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):11-2. PubMed ID: 23210541
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA-approved drugs to treat schizophrenia.
    J Psychosoc Nurs Ment Health Serv; 2011 Dec; 49(12):11-2. PubMed ID: 22149488
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA-approved drugs to treat Schizophrenia.
    J Psychosoc Nurs Ment Health Serv; 2013 Dec; 51(12):9-10. PubMed ID: 24305693
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA-approved drugs to treat schizophrenia.
    J Psychosoc Nurs Ment Health Serv; 2014 Dec; 52(12):11-2. PubMed ID: 25453505
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neuroleptics. Pharmacologic evaluation and clinical effect].
    Naess K
    Tidsskr Nor Laegeforen; 1979 Mar; 99(8):441-2. PubMed ID: 34901
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug treatment and schizophrenia in the 1990s.
    Litherland S
    Drugs; 1997 Nov; 54(5):794. PubMed ID: 9360063
    [No Abstract]   [Full Text] [Related]  

  • 38. Schizophrenia drug shines in phase III.
    Kingwell K
    Nat Rev Drug Discov; 2022 Oct; 21(10):702. PubMed ID: 36045284
    [No Abstract]   [Full Text] [Related]  

  • 39. The drug treatment of patients with schizophrenia.
    Drug Ther Bull; 1995 Nov; 33(11):81-6. PubMed ID: 8536545
    [No Abstract]   [Full Text] [Related]  

  • 40. EVALUATION OF ANTIHYPERTENSIVE THERAPY. II. DOUBLE-BLIND CONTROLLED EVALUATION OF MEBUTAMATE.
    BAYRD ED; HAGEDORN AB; MCGUCKIN WF
    JAMA; 1965 Aug; 193():727-9. PubMed ID: 14328472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.